SCHEMBL24897709

SCHEMBL24897709

CC1CC2CC(C1)CC(C)(C(=O)NC(C)C)C2

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
NPC1 O15118 1/20 0.41
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
EPHX2 P34913 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
CYP17A1 P05093 2/20 0.36
CA2 P00918 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25463682 0.80 TSHR (0.37) ALDH1A1NPC1GAAPOLBCYP3A4
SCHEMBL24202163 0.77 GLA (0.39) ALDH1A1GAAEPHX2
SCHEMBL7705993 0.76 ALDH1A1 (0.67) ALDH1A1NPC1CYP17A1CA2
SCHEMBL25463673 0.74 ALDH1A1 (0.33) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL12696686 0.73 ALDH1A1 (0.41) ALDH1A1GAAEPHX2
SCHEMBL19901634 0.71 EPHX2 (0.34) ALDH1A1EPHX2SMN1; SMN2
SCHEMBL18409206 0.71 FFAR3 (0.48) ALDH1A1CA2
SCHEMBL16000695 0.70 CCR2 (0.37) ALDH1A1GAAPOLBEPHX2CA2
SCHEMBL19901636 0.69 KDM4E (0.38) EPHX2
SCHEMBL19426667 0.69 EPHX2 (0.42) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081759-A1 BIFUNCTIONAL PI3K-ALPHA INHIBITORS AND USES THEREOF RELAY THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
WO-2023039532-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-03-16 WO disclosed
WO-2023288242-A1 PI3Kα INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed